Clinical trial
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins…
NCT00422396 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00422396 |
|---|---|
| Title | Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis |
| Official title | Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis |
| Lead sponsor | University of Michigan, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hypertriglyceridemia With the Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Fenofibrate (drug) |
| Enrollment | 60 |
| Start date | Jan 1, 2001 |
| Primary completion | Apr 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | Jan 17, 2007 |
| Last update posted | Feb 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: